Dicronis
Dicronis develops the first lymphatic activity tracker, allowing for the earliest possible detection of lymphedema, a chronic, progressive and debilitating complication of cancer therapies.
Dicronis develops the first lymphatic activity tracker, allowing for the earliest possible detection of lymphedema, a chronic, progressive and debilitating complication of cancer therapies.
